This small molecule is a potent and selective p300 histone acetyltransferase (HAT) inhibitor with an IC50 of 50-500 nM, showing ~100-fold selectivity over PCAF. It effectively blocks p300-dependent transcriptional activity and has demonstrated bioactivity in animal models, making it a valuable tool for epigenetic and cancer research in both cellular and in vivo studies.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
